BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar D, Ison MG, Mira J, Welte T, Hwan Ha J, Hui DS, Zhong N, Saito T, Katugampola L, Collinson N, Williams S, Wildum S, Ackrill A, Clinch B, Lee N. Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial. The Lancet Infectious Diseases 2022;22:718-30. [DOI: 10.1016/s1473-3099(21)00469-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Cilloniz C, Luna CM, Hurtado JC, Marcos MÁ, Torres A. Respiratory viruses: their importance and lessons learned from COVID-19. Eur Respir Rev 2022;31:220051. [PMID: 36261158 DOI: 10.1183/16000617.0051-2022] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Stannard HL, Mifsud EJ, Wildum S, Brown SK, Koszalka P, Shishido T, Kojima S, Omoto S, Baba K, Kuhlbusch K, Hurt AC, Barr IG. Assessing the fitness of a dual-antiviral drug resistant human influenza virus in the ferret model. Commun Biol 2022;5:1026. [PMID: 36171475 DOI: 10.1038/s42003-022-04005-4] [Reference Citation Analysis]
3 Koszalka P, George A, Dhanasekaran V, Hurt AC, Subbarao K. Effect of Baloxavir and Oseltamivir in Combination on Infection with Influenza Viruses with PA/I38T or PA/E23K Substitutions in the Ferret Model. mBio 2022;:e0105622. [PMID: 35938724 DOI: 10.1128/mbio.01056-22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Uyeki TM, Hui DS, Zambon M, Wentworth DE, Monto AS. Influenza. The Lancet 2022;400:693-706. [DOI: 10.1016/s0140-6736(22)00982-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
5 Sridhar S, To KK. Severe influenza: is there a role for antiviral combinations? The Lancet Infectious Diseases 2022;22:574-576. [DOI: 10.1016/s1473-3099(21)00484-9] [Reference Citation Analysis]
6 Lampejo T. Is combination antiviral therapy for influenza the optimal approach? The Lancet Infectious Diseases 2022;22:587-588. [DOI: 10.1016/s1473-3099(22)00212-2] [Reference Citation Analysis]